Who owns AADI BIOSCIENCE INC COM?
- Ticker: AADI
- CUSIP Number: 00032q104
Tip: Access positions for across all investors
Analyze quarterly positions in Aadi Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aadi Bioscience stock
Who bought or sold AADI BIOSCIENCE INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| venBio Select Advisor | 2.8M | $9.0M | 0% | Dec 2024 |
|
| QVT Financial | 2.3M | $7.3M | 100% | Dec 2024 |
|
| BML Capital Management | 2.1M | $6.6M | 5% | Dec 2024 |
|
| Longwood Capital Partners | 1.8M | $5.8M | 0% | Dec 2024 |
|
| Vanguard Group | 766k | $2.4M | 0% | Dec 2024 |
|
| Renaissance Technologies | 456k | $1.4M | -1% | Dec 2024 |
|
| Peapod Lane Capital | 443k | $1.4M | 100% | Dec 2024 |
|
| EcoR1 Capital | 345k | $1.1M | -81% | Dec 2024 |
|
| Soleus Capital Management | 333k | $1.1M | 0% | Dec 2024 |
|
| BlackRock | 244k | $770k | 0% | Dec 2024 |
|
| Geode Capital Management | 217k | $686k | 4% | Dec 2024 |
|
| Millennium Management | 174k | $549k | -2% | Dec 2024 |
|
| Bridgeway Capital Management | 115k | $364k | 24% | Dec 2024 |
|
| Northern Trust | 91k | $288k | 33% | Dec 2024 |
|
| Citadel Advisors | 80k | $253k | 156% | Dec 2024 |
|
| State Street Corporation | 69k | $217k | 0% | Dec 2024 |
|
| Two Sigma Investments | 69k | $216k | 305% | Dec 2024 |
|
| Marquette Asset Management | 64k | $201k | 0% | Dec 2024 |
|
| Two Sigma Advisers | 62k | $195k | 95% | Dec 2024 |
|
| UBS Group | 59k | $187k | 17% | Dec 2024 |
|
| Susquehanna International | 58k | $181k | -20% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 42k | $131k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 40k | $126k | 100% | Dec 2024 |
|
| Dimensional Fund Advisors | 36k | $112k | 0% | Dec 2024 |
|
| ABG Innovation Capital Partners III GP | 27k | $55k | 0% | Sep 2024 |
|
| Prudential Financial | 26k | $83k | 0% | Dec 2024 |
|
| Man Group | 15k | $46k | 0% | Dec 2024 |
|
| XTX Topco | 13k | $42k | -15% | Dec 2024 |
|
| Springbok Capital Management | 13k | $41k | -28% | Dec 2024 |
|
| Morgan Stanley | 13k | $40k | 429% | Dec 2024 |
|
| Point72 Asia | 12k | $37k | -4% | Dec 2024 |
|
| Cubist Systematic Strategies | 6.6k | $21k | 553% | Dec 2024 |
|
| Federated Investors | 4.7k | $15k | -2% | Dec 2024 |
|
| Us Bancorp | 3.3k | $11k | 0% | Dec 2024 |
|
| Russell Investments | 1.5k | $4.8k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 1.5k | $4.7k | -65% | Dec 2024 |
|
| Advisor Group Holdings | 1.4k | $3.0k | 0% | Dec 2024 |
|
| Bartlett & Co. Wealth Management | 1.3k | $4.2k | 0% | Dec 2024 |
|
| Satter Management | 659.00 | $2.1k | 0% | Dec 2024 |
|
| Wells Fargo & Company | 600.00 | $1.9k | -79% | Dec 2024 |
|
| Simplex Trading | 558.00 | $999.991800 | -76% | Dec 2024 |
|
| Group One Trading | 500.00 | $1.6k | 100% | Dec 2024 |
|
| SBI Securities | 428.00 | $1.3k | 100% | Dec 2024 |
|
| Tower Research Capital | 414.00 | $1.3k | -77% | Dec 2024 |
|
| TD Waterhouse Canada | 232.00 | $454.998400 | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 197.00 | $622.007800 | 100% | Dec 2024 |
|
| Bank of America Corporation | 172.00 | $543.004000 | -19% | Dec 2024 |
|
| Point72 | 77.00 | $242.996600 | 0% | Dec 2024 |
|
| Citigroup | 75.00 | $237.000000 | -7% | Dec 2024 |
|
| CWM | 25.00 | $0 | 0% | Dec 2024 |
|
| Parallel Advisors | 8.00 | $25.000000 | 0% | Dec 2024 |
|
Who sold out of Aadi Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Acuitas Investments | Sep 2024 | 439k | $904k |
| Affinity Asset Advisors | Sep 2024 | 47k | $97k |
| Jane Street | Sep 2024 | 26k | $54k |
| GSA Capital Partners | Sep 2024 | 21k | $43k |
| Squarepoint Ops | Sep 2024 | 11k | $22k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 8.1k | $12k |
| Catalyst Funds Management Pty | Jun 2024 | 4.1k | $6.0k |
| FMR | Sep 2024 | 2.6k | $5.4k |